AXON Connected commercializes technology - we turn intellectual property into products.
We pick markets, assemble expert teams, source technologies, create products, and drive our innovations to exits for our investors.
We are currently rapidly commercializing technologies in three core areas - bio molecular devices, information solutions, and optical instruments.
As an intellectual property owner, you can partner with us;
as a subject matter expert, you can work with us;
as an investor, you can invest side-by-side with us;
as a strategic buyer, you can buy from us.
AXON Connected commercializes technology - we turn intellectual property into products.
We pick markets, assemble expert teams, source technologies, create products, and drive our innovations to exits for our investors.
We are currently rapidly commercializing technologies in three core areas - bio molecular devices, information solutions, and optical instruments.
As an intellectual property owner, you can partner with us;
as a subject matter expert, you can work with us;
as an investor, you can invest side-by-side with us;
as a strategic buyer, you can buy from us.
Swarm-based artificial intelligence for autonomously discovering patterns and anomalies, coordinating resources, predicting behavior, and much more
Optical instruments that improve the design and use of fiber optic networks and telecommunications systems
Cancer and rare cell detection
instruments and methods
We are highly experienced in commercializing technologies from individuals, corporations, foundations/non-profits, universities, and the government. Our team has successfully commercialized over 100 products.
We are highly experienced in commercializing technologies from individuals, corporations, foundations/non-profits, universities, and the government. Our team has successfully commercialized over 100 products.
We offer opportunities for investors to invest side-by-side with us in our focus areas. Our team has previously built-up and sold 12 companies.
We offer opportunities for investors to invest side-by-side with us in our focus areas. Our team has previously built-up and sold 12 companies.